Company
Headquarters: Philadelphia, PA, United States
CEO: Mr. Osagie O. Imasogie Esq.
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $991.39 B |
| JPMorgan | $744.02 B |
| Visa | $635.57 B |
| Mastercard | $490.32 B |
| Bank of America | $353.07 B |
Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Ibere Pharmaceuticals has the following listings and related stock indices.
Stock: NYSE: IBER wb_incandescent